Updated on 13 Sep 2026, 11:42 AM IST
|
| ||||
|
| ||||
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,842.00 | -1.18 | 4,41,947.09 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 9,326.00 | -0.84 | 2,47,576.00 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,975.00 | 0.95 | 1,89,226.24 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,365.00 | -1.09 | 1,10,272.68 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,119.50 | 0.13 | 1,11,670.56 | 21.19 | 4.24 | 0.09 | 14.22 |
| Meeting Date | Purpose |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-05-29 | Audited Results & Final Dividend |
| 2026-02-03 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
Rubicon Research is trading at 1845.00 as on Fri Sep 11 2026 09:59:59. This is 3.04% upper as compared to its previous closing price of 1790.55.
The market capitalization of Rubicon Research is 30502.31 Cr as on Fri Sep 11 2026 09:59:59.
The 52 wk high for Rubicon Research is 1896.15 whereas the 52 wk low is 571.00
Rubicon Research can be analyzed on the following key metrics -
Rubicon Research reported a net profit of 246.73 Cr in 2026.
The Mutual Fund Shareholding was 7.23% at the end of 30 Jun 2026.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.